Holocene Advisors
EW icon

Holocene Advisors’s Edwards Lifesciences EW Stock Holding History

Holocene Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-703,600
Closed -$82.8M – 877
2022
Q1 		$82.8M Buy
+703,600
New +$78.9M 0.43% 73
2021
Q4 		– Sell
-279,000
Closed -$31.6M – 897
2021
Q3 		$31.6M Sell
279,000
-333,500
-54% -$38.1M 0.17% 163
2021
Q2 		$63.4M Buy
+612,500
New +$57.7M 0.36% 101

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Holocene Advisors's EW Position: Q2 2026 in Review

Holocene Advisors increased its Edwards Lifesciences (EW) stake by 325% in Q2 2026, buying an estimated $201M and bringing the position to 3,139,285 shares worth $284M. The position accounts for 0.64% of the portfolio, ranked #33.

Holocene Advisors first reported a position in EW in Q4 2017 and has held it in 28 quarters since. The position peaked at $369M in Q3 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Holocene Advisors held 3,139,285 shares of Edwards Lifesciences worth $284M as of Q2 2026.
  • Holocene Advisors bought 2,401,186 Edwards Lifesciences shares in Q2 2026, an estimated $201M.
  • Edwards Lifesciences made up 0.64% of Holocene Advisors's portfolio in Q2 2026, its #33 holding.
  • Holocene Advisors first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 28 quarters since.
  • Holocene Advisors's Edwards Lifesciences position peaked at $369M in Q3 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.